Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents-Reference-Cited by-同舟云学术

Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents

Published:2021-09 Issue: Volume:907 Page:174222
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Zou Xiao-zheng,Zhou Xiu-hua,Feng Ying-qi,Hao Jun-feng,Liang Bing,Jia Meng-wei

Publisher

Elsevier BV

Subject

Pharmacology

Reference54 articles.

1. Epidemiology of esophageal squamous cell carcinoma;Abnet;Gastroenterology,2018

2. Cancer stem cells revisited;Batlle;Nat. Med.,2017

3. Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480;Butler;Biochem. Biophys. Res. Commun.,2017

4. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression;Cao;Nat. Commun.,2019

5. Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness;Chang,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Mapping Study of detection of Tumor Cell Targeted by Enzymes though Cerebrospinal Fluid;Clinical Cancer Investigation Journal;2023

2. MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells;Frontiers in Oncology;2022-08-29

3. Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs;Frontiers in Pharmacology;2022-06-07

4. Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA;Frontiers in Oncology;2022-05-30

5. A Novel Small-Molecule Inhibitor of SREBP-1 Based on Natural Product Monomers Upregulates the Sensitivity of Lung Squamous Cell Carcinoma Cells to Antitumor Drugs;Frontiers in Pharmacology;2022-05-18